Intensive CareBIRMAnieNCT07886619
Implicit Bias in Intensive Care: Analysis and Assessment.
An observational study of Intensive Care, run by University Hospital, Bordeaux at 1 site in France.
Trial summary
This study uses clinical vignettes to explore how healthcare professionals make complex ethical decisions in intensive care settings. Participants evaluate several simulated scenarios, and their responses are analyzed to better understand decision making patterns. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Intensive Care
- How many people
- 1,000 participants
- Where
- 1 siteFrance
- Study dates
- Dec 2026to Mar 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Healthcare professionals working in intensive care units
Who may be able to join
- Healthcare professionals working in intensive care units, including:
- physicians (residents, fellows, attendings),
- nurses,
- nurse assistants.
Who cannot join
- No criteria
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Florence FRANCIS-OLIVIERO, Dr contact
France1 site
Hopital Pellegrin
Bordeaux, 33000
Alexandre BOYER, Pr, 556795679 ext. +33, alexandre.boyer@chu-bordeaux.fr
About this study
This study uses clinical vignettes to explore how healthcare professionals make complex ethical decisions in intensive care settings. Participants evaluate several simulated scenarios, and their responses are analyzed to better understand decision making patterns.
Read the detailed description
The project investigates how clinicians assess and manage severe neurological cases through standardized vignette based simulations. The study aims to characterize variability in clinical judgments across different professional groups.
- Conditions
- Intensive Care
- Keywords
- Ethical decision, Intensive care
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Healthcare professional | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Decision rating on a 4 point Likert scale
Participants indicate how strongly they support a specific management option in each vignette
Measured: at inclusion day
Secondary outcomes (2)
Decision rating for ICU admission (Likert scale)
Participants indicate how strongly they support an ICU admission in each vignette
Measured: at inclusion day
Association between decision patterns and respondent characteristics
The decisions made by participants will be evaluated based on several criteria related to their own characteristics. (profession, experience, age, etc.)
Measured: at inclusion day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Oct 2026
- Study startDec 2026 (estimated)
- Primary completionMar 2027 (estimated)
- Study completionMar 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Intensive CareStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 1,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Bordeaux
- Sponsor type
- University, hospital or other
- Collaborators
- Institut de Recherche et Documentation en Economie de la Santé, France
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07886619
- Sponsor's protocol ID
- CHUBX 2025/130
- Acronym
- BIRMAnie
- Status last verified
- Oct 2026
- First submitted
- 14 Oct 2026
- Last updated
- 21 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Implicit Bias in Intensive Care: Analysis and Assessment.
- ClinicalTrials.gov ID
- NCT07886619
- Acronym / sponsor ID
- BIRMAnie / CHUBX 2025/130
- Conditions
- Intensive Care
- Keywords
- Ethical decision, Intensive care
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- University Hospital, BordeauxUniversity, hospital or other
- Collaborators
- Institut de Recherche et Documentation en Economie de la Santé, France
- Study start
- Dec 2026 (estimated)
- Primary completion
- Mar 2027 (estimated)
- Study completion
- Mar 2027 (estimated)
- First posted
- 21 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study uses clinical vignettes to explore how healthcare professionals make complex ethical decisions in intensive care settings. Participants evaluate several simulated scenarios, and their responses are analyzed to better understand decision making patterns.
Detailed description
The project investigates how clinicians assess and manage severe neurological cases through standardized vignette based simulations. The study aims to characterize variability in clinical judgments across different professional groups.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Healthcare professional | – | – |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Healthcare professionals working in intensive care units
Key inclusion criteria (4 listed)
- physicians (residents, fellows, attendings),
- nurses,
- nurse assistants.
Key exclusion criteria (1 listed)
- No criteria
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Decision rating on a 4 point Likert scale
Time frame: at inclusion day
Participants indicate how strongly they support a specific management option in each vignette
2 secondary outcomes
Decision rating for ICU admission (Likert scale)
Time frame: at inclusion day
Association between decision patterns and respondent characteristics
Time frame: at inclusion day
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Oct 2026.
Related trials for Intensive Care
Recruiting
Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock
Sepsis - to Reduce Mortality in the Intensive Care Unit, Septic Shock
Recruiting
Effectiveness of Virtual Reality in Improving Upper Limb Function in Critically Ill Patients
Intensive Care Unit (ICU) Acquired Weakness (ICU - AW), Critical Illness
Recruiting
The Effect of Digitally Enabled District (DED 2.0) Ecosystem on the Completeness and Timeliness of Maternal and Neonatal Services in Primary Health Care
Digital Health, Maternal Health Services
Not yet recruiting
Family-partnered Delirium Prevention, Detection, and Management in the ICU
Delirium, Intensive Care Unit Delirium
Not yet recruiting
Visual and Auditory Stimulation in Intensive Care Patients
Dyspnea, Sleep Quality
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Florence FRANCIS-OLIVIERO, Dr contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Intensive Care, run by University Hospital, Bordeaux at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 21 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Alexandre BOYER, Pr (556795679 ext. +33, alexandre.boyer@chu-bordeaux.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Decision rating on a 4 point Likert scale (time frame: at inclusion day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2026; AzTrials last refreshed its copy on 30 Oct 2026.